Skip to content

Blog

Select a tag
Raising NAD+ With Nicotinamide Riboside Resolved Social Deficits in Autism Mouse Model

Raising NAD+ With Nicotinamide Riboside Resolved Social Deficits in Autism Mouse Model

Raising NAD+ With Nicotinamide Riboside Resolved Social Deficits in Autism Mouse Model
Autism Spectrum Disorder

Raising NAD+ With Nicotinamide Riboside Resolved Social Deficits in Autism Mouse Model

An autism model developed in male mice supplemented with nicotinamide riboside (NR) was found to have restored levels of the neurotransmitter oxytocin and improved social behavior.

Read more
Nicotinamide Riboside Supplementation Improves Ataxia Scores and Increases Antibody Levels in Ataxia Telangiectasia Patients
Ataxia Telangiectasia

Nicotinamide Riboside Supplementation Improves Ataxia Scores and Increases Antibody Levels in Ataxia Telangiectasia Patients

Ataxia telangiectasia (AT) is a rare, inherited neurodegenerative disorder characterized by cerebellar degeneration, immunodeficiency, and cancer predisposition. Previous preclinical research has s...

Read more
Nicotinamide Riboside Helps Protect Nerve Fibers During Chemotherapy and Enhances Paclitaxel’s Tumor-suppressing Effects in Animal Models
Cancer

Nicotinamide Riboside Helps Protect Nerve Fibers During Chemotherapy and Enhances Paclitaxel’s Tumor-suppressing Effects in Animal Models

Raising NAD+ levels with nicotinamide riboside has been shown, in animal models, to reduce pain resulting from the cancer treating drug therapy paclitaxel. When administered to rodents in combinati...

Read more
Combined Metabolic Activators (CMAs) Improves Cognitive Functions in Alzheimer’s Disease
Alzheimer's Disease

Combined Metabolic Activators (CMAs) Improves Cognitive Functions in Alzheimer’s Disease

Results of a new phase 2 clinical study assessing whether administration of a mixture of Combined Metabolic Activators (CMAs) including NAD+ precursor nicotinamide riboside (NR) could treat Alzheim...

Read more
Combined Metabolic Activators (CMAs) Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease
Neurological Health

Combined Metabolic Activators (CMAs) Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease

A new study assessing whether administration of a mixture of Combined Metabolic Activators (CMAs), including NAD+ precursor nicotinamide riboside (NR), could treat Parkinson’s disease patients, is ...

Read more
Increasing Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Reduced Neurodegeneration, and Increased Lifespan in Preclinical Model
Alzheimer's Disease

Increasing Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Reduced Neurodegeneration, and Increased Lifespan in Preclinical Model

The human body is composed of cells in the trillions. Each cell relies on a resource molecule called NAD+ for the generation of energy we know as ATP. This energy helps cells perform their unique f...

Read more
Two Experts Weigh In On Energy and Brain Health
Alzheimer's Disease

Two Experts Weigh In On Energy and Brain Health

Most of us are aware there are steps we can take to support the health of our hearts, teeth, eyes, and other vital organs. But when it comes to our brains, we’re often stumped.

Read more
Alzheimer's Disease

NR Promotes Mitochondrial Health and Protects Against Alzheimer’s Disease in Multiple Preclinical Models

Alzheimer’s disease is a chronic condition in which a person’s cognitive functions, such as memory, language, and mood, decline with increasing age.

Read more